The U.K. pieced together an ambitious collaboration of researchers and industry leaders to create an anti-doping facility for the Olympics. And after the athletes are done competing, the research team intends to go on in its own pursuit for the gold. Only they'll be competing in the personalized medicine field, looking for new biomarkers. GlaxoSmithKline ($GSK) is providing the facilities for the Olympics. Story